Moomoo AI 已提取核心訊息
The Vanguard Group has filed an amended Schedule 13G/A with the SEC, indicating a change in their holdings of Ginkgo Bioworks Holdings, Inc. Class A common stock. As of December 29, 2023, The Vanguard Group owns an aggregate amount of 132,779,676 shares, representing 8.20% of the class. This filing, dated February 13, 2024, shows that The Vanguard Group has shared voting power over 461,957 shares and sole dispositive power over 130,958,928 shares, with an additional shared dispositive power over 1,820,748 shares. The filing asserts that the shares were acquired in the ordinary course of business and not with the purpose of changing or influencing the control of the issuer.
The Vanguard Group has filed an amended Schedule 13G/A with the SEC, indicating a change in their holdings of Ginkgo Bioworks Holdings, Inc. Class A common stock. As of December 29, 2023, The Vanguard Group owns an aggregate amount of 132,779,676 shares, representing 8.20% of the class. This filing, dated February 13, 2024, shows that The Vanguard Group has shared voting power over 461,957 shares and sole dispositive power over 130,958,928 shares, with an additional shared dispositive power over 1,820,748 shares. The filing asserts that the shares were acquired in the ordinary course of business and not with the purpose of changing or influencing the control of the issuer.
Vanguard集團已向美國證券交易委員會提交了經修訂的附表13G/A，表明其持有的Ginkgo Bioworks Holdings, Inc.A類普通股發生了變化。截至2023年12月29日，Vanguard集團共擁有132,779,676股股票，佔該類別的8.20％。這份日期爲2024年2月13日的文件顯示，先鋒集團對461,957股股票共享投票權，對130,958,928股股票共享唯一處置權，另外對1,820,748股股票擁有共同處置權。該文件稱，這些股票是在正常業務過程中收購的，其目的不是改變或影響發行人的控制權。
Vanguard集團已向美國證券交易委員會提交了經修訂的附表13G/A，表明其持有的Ginkgo Bioworks Holdings, Inc.A類普通股發生了變化。截至2023年12月29日，Vanguard集團共擁有132,779,676股股票，佔該類別的8.20％。這份日期爲2024年2月13日的文件顯示，先鋒集團對461,957股股票共享投票權，對130,958,928股股票共享唯一處置權，另外對1,820,748股股票擁有共同處置權。該文件稱，這些股票是在正常業務過程中收購的，其目的不是改變或影響發行人的控制權。
有用
沒用